Leonardo F L Rizzo, Daniela L Mana, Héctor A Serra, Karina Danilowicz
Medicina 2020Hyperprolactinemia may be associated with psychiatric disorders in the context of two scenarios: antipsychotic-induced hyperprolactinemia and psychiatric disorders arising from the medical treatment of hyperprolactinemia. Both situations are particularly common in psychiatric and endocrine clinical practice, albeit generally underestimated or unrecognized. The aim of this article is to provide tools for the diagnosis and treatment of hyperprolactinemia associated with psychiatric disorders to raise awareness, especially among psychiatrists and endocrinologists, so that these professionals can jointly focus on the appropriate management of this clinical entity.
Leonardo F L Rizzo, Daniela L Mana, Héctor A Serra, Karina Danilowicz. Hyperprolactinemia associated with psychiatric disorders. Medicina. 2020;80(6):670-680
PMID: 33254112
View Full Text